Artios Pharma Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer

Artios Pharma Limited (“Artios”), a leading DNA Damage Response (DDR) company developing a broad pipeline of precision medicines for the treatment of cancer, announces the appointment of Abid Ansari as Chief Financial Officer (CFO).

Abid will lead the company’s financial, investor relations, and public relations operations, where he brings a variety of US financial experience to Artios, including a background with global public companies in corporate finance, business development, licensing, and investor relations. He joins Tania Dimitrova, Chief Business Officer, in the company’s US subsidiary established since 2019.

Read more….

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...